Abilify (aripiprazole) is a prescription antipsychotic medication that treats depression, schizophrenia, and bipolar disorder. Some side effects may include: headaches, nausea, vomitting, and ...

Preliminary analyses suggest that Cobenfy as an adjunctive treatment to an atypical antipsychotic was associated ... 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys.

This list does not contain all drugs that may ... consider joining The National Pregnancy Registry for Atypical Antipsychotics. This registry helps collect information on the safety of taking ...

This study adds to the growing list of genes that could serve as ... be able to have an immediate impact,” she says. Two atypical antipsychotics have been approved by the US Food and Drug ...

Introduction Atypical antipsychotics have been studied to treat autism spectrum ... we will investigate the distribution of presumed effect modifiers across treatment comparisons. The list of ...

The Phase 3 test evaluated the drug, Cobenfy, as an adjunct to atypical antipsychotics in adults whose schizophrenia symptoms were inadequately controlled by these standard-of-care drugs.

The primary objective is to assess the efficacy of Cobenfy as an adjunctive treatment to one of several atypical antipsychotics compared to placebo with an atypical antipsychotic as measured by ...

Schizophrenia drug Cobenfy, a key component in Bristol Myers Squibb’s plan to navigate a transition period of major loss of ...

All the newer atypical antipsychotics tested cause weight gain, some more than others. Patients with major depressive disorder also frequently require long-term drug treatment, especially those ...

Bristol Myers Squibb's Cobenfy as an adjunctive treatment did not reach the threshold for a statistically significant difference compared to a placebo with an atypical antipsychotic in adults with ...